Fig. 6From: KHDRBS3 accelerates glycolysis and promotes malignancy of hepatocellular carcinoma via upregulating 14-3-3ζKHDRBS3 enhances chemoresistance of HCC cells. (A) Cell viability of HCC cells upon treatment with different concentrations of doxorubicin was assessed by MTT. (B) Flow cytometry analysis of indicated cells with doxorubicin (1 µmol) treatment. Error bars represent standard deviation. **P < 0.01 vs. Vector group or NC− sh groupBack to article page